Rznomics presented Phase 1/2a interim clinical re
Author: Michael
Humacyte presented Phase 3 V012 results at the So
Halia Therapeutics announced that the U.S.
Regeneration Biomedical, Inc.
Elysium Health launched Creatine+, a three-in-one
Fractyl Health reports one-year data suggesting
New peer-reviewed findings suggest tackling two
Following promising results in disease treatment
Agemica founder recognized in King Charles III’s Birthday Honours as his AI-driven longevity platform advances toward in vivo testing. Professor Ronjon Nag, founder and CEO of longevity therapeutics company Agemica, has been appointed an Officer of the Order of the British Empire (OBE) in King Charles III’s Birthday Honours, being recognized for services to entrepreneurship and artificial intelligence [1]. The Birthday Honours are one of two major honours lists published each year as part of the UK’s national honors system, recognizing contributions across science, business, public service and the arts. While the award reflects Nag’s broader career in AI and…
New biomarkers, existing drugs and decades of ce